Publications 2022

Langberg NE, Jenssen TG, Haugen AJ, Mjoen G, Birkeland KI, Asberg A, Hartmann A, Dahle DO (2022)
Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
Transplant. Direct., 8 (1), e1262
DOI 10.1097/TXD.0000000000001262

Publications 2021

Birkeland KI, Bodegard J, Banerjee A, Kim DJ, Norhammar A, Eriksson JW, Thuresson M, Okami S, Ha KH, Kossack N, Mamza JB, Zhang RQ, Yajima T, Komuro I, Kadowaki T (2021)
Lower cardiorenal risk withsodium-glucosecotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
Diabetes Obes. Metab., 23 (1), 75-85
DOI 10.1111/dom.14189

Bleskestad KB, Nordheim E, Lindahl JP, Midtvedt K, Pihlstrom HK, Horneland R, Lee S, Asberg A, Jenssen TG, Birkeland KI (2021)
Insulin secretion and action after pancreas transplantation. A retrospective single-center study
Scand. J. Clin. Lab. Invest., 81 (5), 365-370
DOI 10.1080/00365513.2021.1926535

Nordheim E, Lindahl JP, Carlsen RK, Asberg A, Birkeland KI, Horneland R, Boye B, Scholz H, Jenssen TG (2021)
Patient selection for islet or solid organ pancreas transplantation: experiences from a multidisciplinary outpatient-clinic approach
Endocr. Connect., 10 (2), 230-239
DOI 10.1530/EC-20-0519

Sharma A, Birkeland KI, Nermoen I, Qvigstad E, Tran AT, Gulseth HL, Sollid ST, Wium C, Varsi C (2021)
Understanding mechanisms behind unwanted health behaviours in Nordic and South Asian women and how they affect their gestational diabetes follow-ups: A qualitative study
Diabetic Med., 38 (10), e14651
DOI 10.1111/dme.14651

Stene LC, Ruiz PLD, Asvold BO, Bjarko VV, Sorgjerd EP, Njolstad I, Hopstock LA, Birkeland KI, Gulseth HL (2021)
Diabetes in Norway - different methods give different prevalence estimates REPLY
Tidsskr. Nor. Laegeforen., 141 (1), 12

Publications 2020

Birkeland E, Gharagozlian S, Birkeland KI, Valeur J, Mage I, Rud I, Aas AM (2020)
Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial (vol 12, pg 561, 2020)
Eur. J. Nutr., 59 (7), 3339-3340
DOI 10.1007/s00394-020-02314-0

Hansen AMB, Wium C, Lee S, Tierney AC, McCarthy D, Roche HM, Drevon CA, Birkeland KI, Gulseth HL (2020)
Substantial inter-individual variations in insulin secretion and sensitivity across the glucometabolic spectrum
Scand. J. Clin. Lab. Invest., 80 (4), 282-290
DOI 10.1080/00365513.2020.1730433

Haugen AJ, Hallan S, Langberg NE, Dahle DO, Pihlstrom H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjoen G (2020)
Increased long-term risk for hypertension in kidney donors - a retrospective cohort study
Transpl. Int., 33 (5), 536-543
DOI 10.1111/tri.13576

Hjelmesaeth J, Fatima F, Birkeland KI, Svanevik M, Hofso D (2020)
Metabolic surgery: one size fits all? reply
Lancet Diabetes Endocrinol., 8 (4), 273

Nordheim E, Dahle DO, Halden T, Birkeland KI, Asberg A, Hartmann A, Horneland R, Jenssen TG (2020)
Endothelial function after pancreas transplantation-A single-center observational study
Clin. Transplant., 34 (3), e13815
DOI 10.1111/ctr.13815

Ruiz PLD, Bakken IJ, Haberg SE, Tapia G, Hauge SH, Birkeland KI, Gulseth HL, Stene LC (2020)
Higher frequency of hospitalization but lower relative mortality for pandemic influenza in people with type 2 diabetes
J. Intern. Med., 287 (1), 78-86
DOI 10.1111/joim.12984

Stene LC, Ruiz PLD, Asvold BO, Bjarko VV, Sorgjerd EP, Njolstad I, Hopstock LA, Birkeland KI, Gulseth HL (2020)
How many people have diabetes in Norway in 2020?
Tidsskr. Nor. Laegeforen., 140 (17), 1750-1753

Publications 2019

Arora S, Ofstad AP, Ulimoen GR, Birkeland KI, Endresen K, Gullestad L, Johansen OE (2019)
Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation
Cardiovasc. Diabetol., 18, 26
DOI 10.1186/s12933-019-0832-2

Birkeland KI, Bodegard J, Norhammar A, Kuiper JG, Georgiado E, Beekman-Hendriks WL, Thuresson M, Pignot M, Herings RMC, Kooy A (2019)
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
Diabetes Obes. Metab., 21 (4), 968-974
DOI 10.1111/dom.13612

Birkeland KI, Grill V, Wium C, McQueen MJ, Lopez-Jaramillo P, Lee SF, Gerstein HC (2019)
The association of basal insulin treatment versus standard care with outcomes in anti-GAD positive and negative subjects: A post-hoc analysis of the ORIGIN trial
Diabetes Obes. Metab., 21 (2), 429-433
DOI 10.1111/dom.13528

Borgeraas H, Hjelmesaeth J, Birkeland KI, Fatima F, Grimnes JO, Gulseth HL, Halvorsen E, Hertel JK, Hillestad TOW, Johnson LK, Karlsen TI, Kolotkin RL, Kvan NP, Lindberg M, Lorentzen J, Nordstrand N, Sandbu R, Seeberg KA, Seip B, Svanevik M, Valderhaug TG, Hofso D (2019)
Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and beta-cell function in subjects with morbid obesity: a protocol for the Obesity surgery in Tonsberg (Oseberg) study
BMJ Open, 9 (6), e024573
DOI 10.1136/bmjopen-2018-024573

Davies TT, Graue M, Igland J, Tell GS, Birkeland KI, Peyrot M, Haltbakk J (2019)
Diabetes prevalence among older people receiving care at home: associations with symptoms, health status and psychological well-being
Diabetic Med., 36 (1), 96-104
DOI 10.1111/dme.13790

Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjorgaas MR, Froslie KF, Godang K, Kalvoy H, Martinsen OG, Gulseth HL (2019)
Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia (vol 8, 14722, 2018)
Sci Rep, 9, 6347
DOI 10.1038/s41598-019-42218-6

Haugen AJ, Langberg NE, Dahle DO, Pihlstrom H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjoen G (2019)
Long-term risk for kidney donors with hypertension at donation - a retrospective cohort study
Transpl. Int., 32 (9), 960-964
DOI 10.1111/tri.13443

Hofso D, Fatima F, Borgeraas H, Birkeland KI, Gulseth HL, Hertel JK, Johnson LK, Lindberg M, Nordstrand N, Smastuen MC, Stefanovski D, Svanevik M, Valderhaug TG, Sandbu R, Hjelmesaeth J (2019)
Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial
Lancet Diabetes Endocrinol., 7 (12), 912-924
DOI 10.1016/S2213-8587(19)30344-4

Lee S, Kolset SO, Birkeland KI, Drevon CA, Reine TM (2019)
Acute exercise increases syndecan-1 and-4 serum concentrations
Glycoconjugate J., 36 (2), 113-125
DOI 10.1007/s10719-019-09869-z

Lee S, Olsen T, Vinknes KJ, Refsum H, Gulseth HL, Birkeland KI, Drevon CA (2019)
Plasma Sulphur-Containing Amino Acids, Physical Exercise and Insulin Sensitivity in Overweight Dysglycemic and Normal Weight Normoglycemic Men
Nutrients, 11 (1), 10
DOI 10.3390/nu11010010

Tronstad C, Elvebakk O, Staal OM, Kalvoy H, Hogetveit JO, Jenssen TG, Birkeland KI, Martinsen OG (2019)
Non-invasive prediction of blood glucose trends during hypoglycemia
Anal. Chim. Acta, 1052, 37-48
DOI 10.1016/j.aca.2018.12.009

Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rodevand L, Melle I, Andreassen OA, Molden E, Jonsson EG (2019)
Adipokine levels are associated with insulin resistance in antipsychotics users independently of BMI
Psychoneuroendocrinology, 103, 87-95
DOI 10.1016/j.psyneuen.2019.01.001

Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rodevand L, Melle I, Andreassen OA, Molden E, Jonsson EG (2019)
Response: Are thyroid abnormalities only related to antipsychotic treatment in patients with severe mental disorders?
J. Psychiatr. Res., 117, 150
DOI 10.1016/j.jpsychires.2018.11.012

Publications 2018

Birkeland K (2018)
THE MASTERY OF LIFE WITH DIABETES Type I
Tidsskr. Nor. Laegeforen., 138 (18), 1767

Cavender MA, Norhammar A, Birkeland KI, Jorgensen ME, Wilding JP, Khunti K, Fu AZ, Bodegard J, Blak BT, Wittbrodt E, Thuresson M, Fenici P, Hammar N, Kosiborod M, CVD-REAL Investigators Study Grp (2018)
SGLT-2 Inhibitors and Cardiovascular Risk An Analysis of CVD-REAL
J. Am. Coll. Cardiol., 71 (22), 2497-2506
DOI 10.1016/j.jacc.2018.01.085

Eggemoen AR, Waage CW, Sletner L, Gulseth HL, Birkeland KI, Jenum AK (2018)
Vitamin D, Gestational Diabetes, and Measures of Glucose Metabolism in a Population-Based Multiethnic Cohort
J. Diabetes Res., 2018, 8939235
DOI 10.1155/2018/8939235

Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjorgaas MR, Froslie KF, Godang K, Kalvoy H, Martinsen OG, Gulseth HL (2018)
Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
Sci Rep, 8, 14722
DOI 10.1038/s41598-018-33189-1

Kosiborod M, Birkeland KI, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Jorgensen ME, Wittbrodt ET, Thuresson M, Bodegard J, Hammar N, Fenici P, CVD-REAL Investigators Study Grp (2018)
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study
Diabetes Obes. Metab., 20 (8), 1983-1987
DOI 10.1111/dom.13299

Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jorgensen ME, Thuresson M, Arya N, Bodegard J, Hammar N, Fenici P, CVD-REAL Investigators Study (2018)
Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"
Circulation, 137 (9), 989-991
DOI 10.1161/CIRCULATIONAHA.117.031847

Lee S, Norheim F, Gulseth HL, Langleite TM, Aker A, Gundersen TE, Holen T, Birkeland KI, Drevon CA (2018)
Skeletal muscle phosphatidylcholine and phosphatidylethanolamine respond to exercise and influence insulin sensitivity in men
Sci Rep, 8, 6531
DOI 10.1038/s41598-018-24976-x

Lee S, Norheim F, Gulseth HL, Langleite TM, Aker A, Gundersen TE, Holen T, Birkeland KI, Drevon CA (2018)
Skeletal muscle phosphatidylcholine and phosphatidylethanolamine respond to exercise and influence insulin sensitivity in men (vol 8, 6531, 2018)
Sci Rep, 8, 7885
DOI 10.1038/s41598-018-26061-9

Moen GH, Qvigstad E, Birkeland KI, Evans DM, Sommer C (2018)
Are serum concentrations of vitamin B-12 causally related to cardiometabolic risk factors and disease? A Mendelian randomization study
Am. J. Clin. Nutr., 108 (2), 398-404
DOI 10.1093/ajcn/nqy101

Persson F, Nystrom T, Jorgensen ME, Carstensen B, Gulseth HL, Thuresson M, Fenici P, Nathanson D, Eriksson JW, Norhammar A, Bodegard J, Birkeland KI (2018)
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study
Diabetes Obes. Metab., 20 (2), 344-351
DOI 10.1111/dom.13077

Riiser A, Solbraa A, Jenum AK, Birkeland KI, Andersen LB (2018)
Cycling and walking for transport and their associations with diabetes and risk factors for cardiovascular disease
J. Transp. Health, 11, 193-201
DOI 10.1016/j.jth.2018.09.002

Ruiz PLD, Stene LC, Bakken IJ, Haberg SE, Birkeland KI, Gulseth HL (2018)
Decreasing incidence of pharmacologically and non-pharmacologically treated type 2 diabetes in Norway: a nationwide study
Diabetologia, 61 (11), 2310-2318
DOI 10.1007/s00125-018-4681-4

Sommer C, Lee S, Gulseth HL, Jensen J, Drevon CA, Birkeland KI (2018)
Soluble Leptin Receptor Predicts Insulin Sensitivity and Correlates With Upregulation of Metabolic Pathways in Men
J. Clin. Endocrinol. Metab., 103 (3), 1024-1032
DOI 10.1210/jc.2017-02126

Thuresson M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jorgensen ME, Wittbrodt E, Hammar N, Fenici P, Kosiborod M, CVD-REAL Investigators Study Grp (2018)
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10
Diabetes Care, 41 (6), E106-E108
DOI 10.2337/dc18-0338

Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rodevand L, Melle I, Andreassen OA, Molden E, Jonsson EG (2018)
Free thyroxine and thyroid-stimulating hormone in severe mental disorders: A naturalistic study with focus on antipsychotic medication
J. Psychiatr. Res., 106, 74-81
DOI 10.1016/j.jpsychires.2018.09.014

Publications 2017

Birkeland KI (2017)
Anti-diabetes is just a part of good diabetes treatment!
Tidsskr. Nor. Laegeforen., 137 (18), 1395-1396

Birkeland KI (2017)
TESTOSTERONE
Tidsskr. Nor. Laegeforen., 137 (18), 1453

Birkeland KI, Jorgensen ME, Carstensen B, Persson F, Gulseth HL, Thuresson M, Fenici P, Nathanson D, Nystrom T, Eriksson JW, Bodegard J, Norhammar A (2017)
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis
Lancet Diabetes Endocrinol., 5 (9), 709-717
DOI 10.1016/S2213-8587(17)30258-9

Gorgens SW, Benninghoff T, Eckardt K, Springer C, Chadt A, Melior A, Wefers J, Cramer A, Jensen J, Birkeland KI, Drevon CA, Al-Hasani H, Eckel J (2017)
Hypoxia in Combination With Muscle Contraction Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle via the HIF-1 alpha Pathway
Diabetes, 66 (11), 2800-2807
DOI 10.2337/db16-1488

Gulseth HL, Wium C, Angel K, Eriksen EF, Birkeland KI (2017)
Effects of Vitamin D Supplementation on Insulin Sensitivity and Insulin Secretion in Subjects With Type 2 Diabetes and Vitamin D Deficiency: A Randomized Controlled Trial
Diabetes Care, 40 (7), 872-878
DOI 10.2337/dc16-2302

Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jorgensen ME, Thuresson M, Arya N, Bodegard J, Hammar N, Fenici P, CVD-REAL Investigators Study Grp (2017)
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
Circulation, 136 (3), 249-+
DOI 10.1161/CIRCULATIONAHA.117.029190

Lee S, Norheim F, Gulseth HL, Langleite TM, Kolnes KJ, Tangen DS, Stadheim HK, Gilfillan GD, Holen T, Birkeland KI, Jensen J, Drevon CA (2017)
Interaction between plasma fetuin-A and free fatty acids predicts changes in insulin sensitivity in response to long-term exercise
PHYSIOL. REP., 5 (5), e13183
DOI 10.14814/phy2.13183

Lund J, Rustan AC, Lovsletten NG, Mudry JM, Langleite TM, Feng YZ, Stensrud C, Brubak MG, Drevon CA, Birkeland KI, Kolnes KJ, Johansen EI, Tangen DS, Stadheim HK, Gulseth HL, Krook A, Kase ET, Jensen J, Thoresen GH (2017)
Exercise in vivo marks human myotubes in vitro: Training-induced increase in lipid metabolism
PLoS One, 12 (4), e0175441
DOI 10.1371/journal.pone.0175441

Ofstad AP, Ulimoen GR, Orvik E, Birkeland KI, Gullestad LL, Fagerland MW, Johansen OE (2017)
Long-term follow-up of a hospital-based, multi-intervention programme in type 2 diabetes mellitus: impact on cardiovascular events and death
J. Int. Med. Res., 45 (5), 1535-1552
DOI 10.1177/0300060517707674

Pourteymour S, Eckardt K, Holen T, Langleite T, Lee S, Jensen J, Birkeland KI, Drevon CA, Hjorth M (2017)
Global mRNA sequencing of human skeletal muscle: Search for novel exercise-regulated myokines
Mol. Metab., 6 (4), 352-365
DOI 10.1016/j.molmet.2017.01.007

Pourteymour S, Hjorth M, Lee S, Holen T, Langleite TM, Jensen J, Birkeland KI, Drevon CA, Eckardt K (2017)
Dual specificity phosphatase 5 and 6 are oppositely regulated in human skeletal muscle by acute exercise
PHYSIOL. REP., 5 (19), e13459
DOI 10.14814/phy2.13459

Risstad H, Kristinsson JA, Fagerland MW, le Roux CW, Birkeland KI, Gulseth HL, Thorsby PM, Vincent RP, Engstrom M, Olbers T, Mala T (2017)
Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial
Surg. Obes. Relat. Dis., 13 (9), 1544-1554
DOI 10.1016/j.soard.2017.05.024

Sletner L, Jenum AK, Yajnik CS, Morkrid K, Nakstad B, Rognerud-Jensen OH, Birkeland KI, Vangen S (2017)
Fetal growth trajectories in pregnancies of European and South Asian mothers with and without gestational diabetes, a population-based cohort study
PLoS One, 12 (3), e0172946
DOI 10.1371/journal.pone.0172946

Waage C, Jenum AK, Mdala I, Berg JP, Richardsen K, Birkeland K (2017)
Associations between gestational diabetes mellitus and elevated HbA(1c) early postpartum in a multi-ethnic population
Prim. Care Diabetes, 11 (2), 132-139
DOI 10.1016/j.pcd.2016.09.007

Publications 2016

Eggemoen AR, Falk RS, Knutsen KV, Lagerlov P, Sletner L, Birkeland KI, Jenum AK (2016)
Vitamin D deficiency and supplementation in pregnancy in a multiethnic population-based cohort
BMC Pregnancy Childbirth, 16, 7
DOI 10.1186/s12884-016-0796-0

Gorgens SW, Hjorth M, Eckardt K, Wichert S, Norheim F, Holen T, Lee S, Langleite T, Birkeland KI, Stadheim HK, Kolnes KJ, Tangen DS, Kolnes AJ, Jensen J, Drevon CA, Eckel J (2016)
The exercise-regulated myokine chitinase-3-like protein 1 stimulates human myocyte proliferation
Acta Physiol., 216 (3), 330-345
DOI 10.1111/apha.12579

Hjorth M, Pourteymour S, Gorgens SW, Langleite TM, Lee S, Holen T, Gulseth HL, Birkeland KI, Jensen J, Drevon CA, Norheim F (2016)
Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cells
Acta Physiol., 217 (1), 45-60
DOI 10.1111/apha.12631

Langleite TM, Jensen J, Norheim F, Gulseth HL, Tangen DS, Kolnes KJ, Heck A, Storas T, Grothe G, Dahl MA, Kielland A, Holen T, Noreng HJ, Stadheim HK, Bjornerud A, Johansen EI, Nellemann B, Birkeland KI, Drevon CA (2016)
Insulin sensitivity, body composition and adipose depots following 12 w combined endurance and strength training in dysglycemic and normoglycemic sedentary men
Arch. Physiol. Biochem., 122 (4), 167-179
DOI 10.1080/13813455.2016.1202985

Lee S, Norheim F, Langleite TM, Noreng HJ, Storas TH, Afman LA, Frost G, Bell JD, Thomas EL, Kolnes KJ, Tangen DS, Stadheim HK, Gilfillan GD, Gulseth HL, Birkeland KI, Jensen J, Drevon CA, Holen T, NutriTech Consortium (2016)
Effect of energy restriction and physical exercise intervention on phenotypic flexibility as examined by transcriptomics analyses of mRNA from adipose tissue and whole body magnetic resonance imaging
PHYSIOL. REP., 4 (21), e13019
DOI 10.14814/phy2.13019

Punthakee Z, Gerstein HC, Bosch J, Tyrwhitt J, Jung H, Lee SF, Lonn E, Marsden T, McKelvie R, McQueen MJ, Morillo CA, Yusuf S, Dagenais GR, Diaz R, Maggioni AP, Probstfield J, Ramachandran A, Riddle MC, Ryden LE, Badings EA, Birkeland KI, Cardona E, Commerford P, Davies M, Fodor JG et al. (2016)
Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE)
Diabetes Care, 39 (5), 709-716
DOI 10.2337/dc15-1676

Sommer C, Gulseth HL, Jenum AK, Sletner L, Thorsby PM, Birkeland KI (2016)
Soluble Leptin Receptor and Risk of Gestational Diabetes in a Multiethnic Population: A Prospective Cohort Study
J. Clin. Endocrinol. Metab., 101 (11), 4070-4075
DOI 10.1210/jc.2016-2583

Waage CW, Falk RS, Sommer C, Morkrid K, Richardsen KR, Baerug A, Shakeel N, Birkeland KI, Jenum AK (2016)
Ethnic differences in postpartum weight retention: a Norwegian cohort study
BJOG, 123 (5), 699-708
DOI 10.1111/1471-0528.13321

Waage CW, Mdala I, Jenum AK, Michelsen TM, Birkeland KI, Sletner L (2016)
Ethnic differences in blood pressure from early pregnancy to postpartum: a Norwegian cohort study
J. Hypertens., 34 (6), 1151-1159
DOI 10.1097/HJH.0000000000000918

Publications 2015

Birkeland KI (2015)
Hyperglycaemia in pregnancy: still a lot to learn
Lancet Diabetes Endocrinol., 3 (10), 752-753
DOI 10.1016/S2213-8587(15)00282-X

Birkeland KI (2015)
Hypoglycaemia in clinical diabetes
Tidsskr. Nor. Laegeforen., 135 (9), 876
DOI 10.4045/tidsskr.15.0222

Hofso D, Birkeland KI, Holst JJ, Bollerslev J, Sandbu R, Roislien J, Hjelmesaeth J (2015)
Gastric bypass surgery has a weight-loss independent effect on post-challenge serum glucose levels
Diabetol. Metab. Syndr., 7, 69
DOI 10.1186/s13098-015-0066-8

Ofstad AP, Urheim S, Dalen H, Orvik E, Birkeland KI, Gullestad L, Fagerland MW, Johansen OE, Aakhus S (2015)
Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls?
J. Diabetes, 7 (6), 779-790
DOI 10.1111/1753-0407.12239

Risstad H, Sovik TT, Engstrom M, Aasheim ET, Fagerland MW, Olsen MF, Kristinsson JA, le Roux CW, Bohmer T, Birkeland KI, Mala T, Olbers T (2015)
Five-Year Outcomes After Laparoscopic Gastric Bypass and Laparoscopic Duodenal Switch in Patients With Body Mass Index of 50 to 60 A Randomized Clinical Trial
JAMA Surg., 150 (4), 352-361
DOI 10.1001/jamasurg.2014.3579

Sommer C, Jenum AK, Waage CW, Morkrid K, Sletner L, Birkeland KI (2015)
Ethnic differences in BMI, subcutaneous fat, and serum leptin levels during and after pregnancy and risk of gestational diabetes
Eur. J. Endocrinol., 172 (6), 649-656
DOI 10.1530/EJE-15-0060

Sommer C, Sletner L, Morkrid K, Jenum AK, Birkeland KI (2015)
Effects of early pregnancy BMI, mid-gestational weight gain, glucose and lipid levels in pregnancy on offspring's birth weight and subcutaneous fat: a population-based cohort study
BMC Pregnancy Childbirth, 15, 84
DOI 10.1186/s12884-015-0512-5

Publications 2014

Berntsen S, Richardsen KR, Morkrid K, Sletner L, Birkeland KI, Jenum AK (2014)
Objectively recorded physical activity in early pregnancy: A multiethnic population-based study
Scand. J. Med. Sci. Sports, 24 (3), 594-601
DOI 10.1111/sms.12034

Bordeleau L, Yakubovich N, Dagenais GR, Rosenstock J, Probstfield J, Yu PC, Ryden LE, Pirags V, Spinas GA, Birkeland KI, Ratner RE, Marin-Neto JA, Keltai M, Riddle MC, Bosch J, Yusuf S, Gerstein HC, ORIGIN Trial Investigators (2014)
The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia
Diabetes Care, 37 (5), 1360-1366
DOI 10.2337/dc13-1468

Gulseth HL, Risstad H, Birkeland KI (2014)
Bariatric Surgery versus Intensive Medical Therapy for Diabetes
N. Engl. J. Med., 371 (7), 681

Li YC, Lee S, Langleite T, Norheim F, Pourteymour S, Jensen J, Stadheim HK, Storas TH, Davanger S, Gulseth HL, Birkeland KI, Drevon CA, Holen T (2014)
Subsarcolemmal lipid droplet responses to a combined endurance and strength exercise intervention
PHYSIOL. REP., 2 (11), e12187
DOI 10.14814/phy2.12187

Morkrid K, Jenum AK, Berntsen S, Sletner L, Richardsen KR, Vangen S, Holme I, Birkeland KI (2014)
Objectively recorded physical activity and the association with gestational diabetes
Scand. J. Med. Sci. Sports, 24 (5), E389-E397
DOI 10.1111/sms.12183

Norheim F, Hjorth M, Langleite TM, Lee S, Holen T, Bindesboll C, Stadheim HK, Gulseth HL, Birkeland KI, Kielland A, Jensen J, Dalen KT, Drevon CA (2014)
Regulation of angiopoietin-like protein 4 production during and after exercise
PHYSIOL. REP., 2 (8), e12109
DOI 10.14814/phy2.12109

Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A, Stadheim HK, Gulseth HL, Birkeland KI, Jensen J, Drevon CA (2014)
The effects of acute and chronic exercise on PGC-1 alpha, irisin and browning of subcutaneous adipose tissue in humans
FEBS J., 281 (3), 739-749
DOI 10.1111/febs.12619

Ofstad AP, Johansen OE, Gullestad L, Birkeland KI, Orvik E, Fagerland MW, Urheim S, Aakhus S (2014)
Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi-intervention in type 2 diabetes: The randomized controlled Asker and Baerum Cardiovascular Diabetes (ABCD) study
Am. Heart J., 168 (3), 280-U71
DOI 10.1016/j.ahj.2014.03.026

Sachse D, Baerug A, Sletner L, Birkeland KI, Nakstad B, Jenum AK, Berg JP (2014)
Urine NMR metabolomics analysis of breastfeeding biomarkers during and after pregnancy in a large prospective cohort study
Scand. J. Clin. Lab. Invest., 74 (3), 264-272
DOI 10.3109/00365513.2014.884240

Sletner L, Jenum AK, Morkrid K, Vangen S, Holme IM, Birkeland KI, Nakstad B (2014)
Maternal Life Course Socio-Economic Position and Offspring Body Composition at Birth in a Multi-Ethnic Population
Paediatr. Perinat. Epidemiol., 28 (5), 445-454
DOI 10.1111/ppe.12137

Sommer C, Morkrid K, Jenum AK, Sletner L, Mosdol A, Birkeland KI (2014)
Weight gain, total fat gain and regional fat gain during pregnancy and the association with gestational diabetes: a population-based cohort study
Int. J. Obes., 38 (1), 76-81
DOI 10.1038/ijo.2013.185

Strom H, Selmer R, Birkeland KI, Schirmer H, Berg TJ, Jenum AK, Midthjell K, Berg C, Stene LC (2014)
No increase in new users of blood glucose-lowering drugs in Norway 2006-2011: a nationwide prescription database study
BMC Public Health, 14, 520
DOI 10.1186/1471-2458-14-520

Wium C, Eggesbo HB, Ueland T, Michelsen AE, Torjesen PA, Aukrust P, Birkeland K (2014)
Adipose tissue distribution in relation to insulin sensitivity and inflammation in Pakistani and Norwegian subjects with type 2 diabetes
Scand. J. Clin. Lab. Invest., 74 (8), 700-707
DOI 10.3109/00365513.2014.953571

Publications 2013

Gulseth HL, Gjelstad IMF, Birkeland KI, Drevon CA (2013)
Vitamin D and the Metabolic Syndrome
Current Vascular Pharmacology, 11 (6), 968-984
DOI 10.2174/15701611113119990169

Meneghini L, Atkin SL, Gough SCL, Raz I, Blonde L, Shestakova M, Bain S, Johansen T, Begtrup K, Birkeland KI, NN1250-3668 BEGIN FLEX Trial Inves (2013)
The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes
Diabetes Care, 36 (4), 858-864
DOI 10.2337/dc12-1668

Ofstad AP, Gullestad L, Orvik E, Aakhus S, Endresen K, Ueland T, Aukrust P, Fagerland MW, Birkeland KI, Johansen OE (2013)
Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Baerum Cardiovascular Diabetes (ABCD) cohort study
Cardiovasc. Diabetol., 12, 126
DOI 10.1186/1475-2840-12-126

Sletner L, Nakstad B, Yajnik CS, Morkrid K, Vangen S, Vardal MH, Holme IM, Birkeland KI, Jenum AK (2013)
Ethnic Differences in Neonatal Body Composition in a Multi-Ethnic Population and the Impact of Parental Factors: A Population-Based Cohort Study
PLoS One, 8 (8), e73058
DOI 10.1371/journal.pone.0073058

Sommer C, Sletner L, Jenum AK, Morkrid K, Andersen LF, Birkeland KI, Mosdol A (2013)
Ethnic differences in maternal dietary patterns are largely explained by socio-economic score and integration score: a population-based study
Food Nutr. Res., 57, 21164
DOI 10.3402/fnr.v57i0.21164

Tran AT, Straand J, Dalen I, Birkeland KI, Claudi T, Cooper JG, Meyer HE, Jenum AK (2013)
Pharmacological primary and secondary cardiovascular prevention among diabetic patients in a multiethnic general practice population: still room for improvements
BMC Health Serv. Res., 13, 182
DOI 10.1186/1472-6963-13-182

Wium C, Gulseth HL, Eriksen EF, Birkeland KI (2013)
Characteristics of Glucose Metabolism in Nordic and South Asian Subjects with Type 2 Diabetes
PLoS One, 8 (12), e83983
DOI 10.1371/journal.pone.0083983

Wium C, Aasheim ET, Ueland T, Michelsen AE, Thorsby PM, Larsen IF, Torjesen PA, Aukrust P, Birkeland KI (2013)
Differences in insulin sensitivity, lipid metabolism and inflammation between young adult Pakistani and Norwegian patients with type 2 diabetes: a cross sectional study
BMC Endocr. Disord., 13, 49
DOI 10.1186/1472-6823-13-49

Publications 2012

Gjelstad IMF, Haugen F, Gulseth HL, Norheim F, Jans A, Bakke SS, Raastad T, Tjonna AE, Wisloff U, Blaak EE, Riserus U, Gaster M, Roche HM, Birkeland KI, Drevon CA (2012)
Expression of perilipins in human skeletal muscle in vitro and in vivo in relation to diet, exercise and energy balance
Arch. Physiol. Biochem., 118 (1), 22-30
DOI 10.3109/13813455.2011.630009

Haukeland JW, Dahl TB, Yndestad A, Gladhaug IP, Loberg EM, Haaland T, Konopski Z, Wium C, Aasheim ET, Johansen OE, Aukrust P, Halvorsen B, Birkeland KI (2012)
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
Eur. J. Endocrinol., 166 (3), 503-510
DOI 10.1530/EJE-11-0864

Home PD, Meneghini L, Wendisch U, Ratner RE, Johansen T, Christensen TE, Jendle J, Roberts AP, Birkeland KI (2012)
Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes
Diabetic Med., 29 (6), 716-720
DOI 10.1111/j.1464-5491.2011.03547.x

Jenum AK, Diep LM, Holmboe-Ottesen G, Holme IMK, Kumar BN, Birkeland KI (2012)
Diabetes susceptibility in ethnic minority groups from Turkey, Vietnam, Sri Lanka and Pakistan compared with Norwegians - the association with adiposity is strongest for ethnic minority women
BMC Public Health, 12, 150
DOI 10.1186/1471-2458-12-150

Jenum AK, Morkrid K, Sletner L, Vange S, Torper JL, Nakstad B, Voldner N, Rognerud-Jensen OH, Berntsen S, Mosdol A, Skrivarhaug T, Vardal MH, Holme I, Yajnik CS, Birkeland KI (2012)
Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study
Eur. J. Endocrinol., 166 (2), 317-324
DOI 10.1530/EJE-11-0866

Morkrid K, Jenum AK, Sletner L, Vardal MH, Waage CW, Nakstad B, Vangen S, Birkeland KI (2012)
Failure to increase insulin secretory capacity during pregnancy-induced insulin resistance is associated with ethnicity and gestational diabetes
Eur. J. Endocrinol., 167 (4), 579-588
DOI 10.1530/EJE-12-0452

Sachse D, Sletner L, Morkrid K, Jenum AK, Birkeland KI, Rise F, Piehler AP, Berg JP (2012)
Metabolic Changes in Urine during and after Pregnancy in a Large, Multiethnic Population-Based Cohort Study of Gestational Diabetes
PLoS One, 7 (12), e52399
DOI 10.1371/journal.pone.0052399

Ueland T, Aukrust P, Aakhus S, Smith C, Endresen K, Birkeland KI, Gullestad L, Johansen OE (2012)
Activin A and cardiovascular disease in type 2 diabetes mellitus
Diabetes Vasc. Dis. Res., 9 (3), 234-237
DOI 10.1177/1479164111431171

Publications 2011

Birkeland KI, Home PD, Wendisch U, Ratner RE, Johansen T, Endahl LA, Lyby K, Jendle JH, Roberts AP, DeVries JH, Meneghini LF (2011)
Insulin Degludec in Type 1 Diabetes A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine
Diabetes Care, 34 (3), 661-665
DOI 10.2337/dc10-1925

Sovik TT, Aasheim ET, Taha O, Engstrom M, Fagerland MW, Bjorkman S, Kristinsson J, Birkeland KI, Mala T, Olbers T (2011)
Weight Loss, Cardiovascular Risk Factors, and Quality of Life After Gastric Bypass and Duodenal Switch A Randomized Trial
Ann. Intern. Med., 155 (5), 281-U34
DOI 10.7326/0003-4819-155-5-201109060-00005

Tran AT, Straand J, Diep LM, Meyer HE, Birkeland KI, Jenum AK (2011)
Cardiovascular disease by diabetes status in five ethnic minority groups compared to ethnic Norwegians
BMC Public Health, 11, 554
DOI 10.1186/1471-2458-11-554

Aasheim ET, Elshorbagy AK, Diep LM, Sovik TT, Mala T, Valdivia-Garcia M, Olbers T, Bohmer T, Birkeland KI, Refsum H (2011)
Effect of bariatric surgery on sulphur amino acids and glutamate
Br. J. Nutr., 106 (3), 432-440
DOI 10.1017/S0007114511000201

Publications 2010

Atar D, Birkeland KI, Uhlig T (2010)
'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis
Ann. Rheum. Dis., 69 (4), 629-630
DOI 10.1136/ard.2010.128462

Charbonnel B, DeFronzo R, Davidson J, Schmitz O, Birkeland K, Pirags V, Scheen A, PROactive Investigators (2010)
Pioglitazone Use in Combination with Insulin in the Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive19)
J. Clin. Endocrinol. Metab., 95 (5), 2163-2171
DOI 10.1210/jc.2009-1974

Dahl TB, Haukeland JW, Yndestad A, Ranheim T, Gladhaug IP, Damas JK, Haaland T, Loberg EM, Arntsen B, Birkeland K, Bjoro K, Ulven SM, Konopski Z, Nebb HI, Aukrust P, Halvorsen B (2010)
Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease
J. Clin. Endocrinol. Metab., 95 (6), 3039-3047
DOI 10.1210/jc.2009-2148

Gulseth HL, Gjelstad IMF, Tierney AC, Lovegrove JA, Defoort C, Blaak EE, Lopez-Miranda J, Kiec-Wilk B, Riserus U, Roche HM, Drevon CA, Birkeland KI (2010)
Serum Vitamin D Concentration Does Not Predict Insulin Action or Secretion in European Subjects With the Metabolic Syndrome
Diabetes Care, 33 (4), 923-925
DOI 10.2337/dc09-1692

Gulseth HL, Gjelstad IMF, Tierney AC, Shaw DI, Helal O, van Hees AMJ, Delgado-Lista J, Leszczynska-Golabek I, Karlstrom B, Lovegrove J, Defoort C, Blaak EE, Lopez-Miranda J, Dembinska-Kiec A, Riserus U, Roche HM, Birkeland KI, Drevon CA (2010)
Dietary fat modifications and blood pressure in subjects with the metabolic syndrome in the LIPGENE dietary intervention study
Br. J. Nutr., 104 (2), 160-163
DOI 10.1017/S0007114510000565

Hallen J, Johansen OE, Birkeland KI, Gullestad L, Aakhus S, Endresen K, Tjora S, Jaffe AS, Atar D (2010)
Determinants and prognostic implications of Cardiac Troponin T measured by a sensitive assay in Type 2 Diabetes Mellitus
Cardiovasc. Diabetol., 9, 52
DOI 10.1186/1475-2840-9-52

Jenum AK, Sletner L, Voldner N, Vangen S, Morkrid K, Andersen LF, Nakstad B, Skrivarhaug T, Rognerud-Jensen OH, Roald B, Birkeland KI (2010)
The STORK Groruddalen research programme: A population-based cohort study of gestational diabetes, physical activity, and obesity in pregnancy in a multiethnic population. Rationale, methods, study population, and participation rates
Scand. J. Public Health, 38 5, 60-70
DOI 10.1177/1403494810378921

Parhofer KG, Birkeland KI, DeFronzo R, Del Prato S, Bhaumik A, Ptaszynska A (2010)
Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND)
Int. J. Clin. Pract., 64 (2), 160-168
DOI 10.1111/j.1742-1241.2009.02246.x

Solaas K, Legry V, Retterstol K, Berg PR, Holven KB, Ferrieres J, Amouyel P, Lien S, Romeo J, Valtuena J, Widhalm K, Ruiz JR, Dallongeville J, Tonstad S, Rootwelt H, Halvorsen B, Nenseter MS, Birkeland KI, Thorsby PM, Meirhaeghe A, Nebb HI (2010)
Suggestive evidence of associations between liver X receptor beta polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)
BMC Med. Genet., 11, 144
DOI 10.1186/1471-2350-11-144

Tran AT, Diep LM, Cooper JG, Claudi T, Straand J, Birkeland K, Ingskog W, Jenum AK (2010)
Quality of care for patients with type 2 diabetes in general practice according to patients' ethnic background: a cross-sectional study from Oslo, Norway
BMC Health Serv. Res., 10, 145
DOI 10.1186/1472-6963-10-145

Aasheim ET, Frigstad SO, Sovik TT, Birkeland KI, Haukeland JW (2010)
Hyperinsulinemic hypoglycemia and liver cirrhosis presenting after duodenal switch: a case report
Surg. Obes. Relat. Dis., 6 (4), 441-443
DOI 10.1016/j.soard.2009.11.007

Publications 2009

Birkenaes AB, Birkeland KI, Friis S, Opjordsmoen S, Andreassen OA (2009)
Hormonal Markers of Metabolic Dysregulation in Patients With Severe Mental Disorders After Olanzapine Treatment Under Real-Life Conditions
J. Clin. Psychopharmacol., 29 (2), 109-116
DOI 10.1097/JCP.0b013e31819b95fc

Haukeland JW, Konopski Z, Eggesbo HB, Von Volkmann HL, Raschpichler G, Bjoro K, Haaland T, Loberg EM, Birkeland K (2009)
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
Scand. J. Gastroenterol., 44 (7), 853-860
DOI 10.1080/00365520902845268

Johansen OE, Birkeland KI, Jorgensen AP, Orvik E, Sorgard B, Torjussen BR, Ueland T, Aukrust P, Gullestad L (2009)
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial
J. Diabetes, 1 (3), 182-187
DOI 10.1111/j.1753-0407.2009.00031.x

Thorsby PM, Midthjell K, Gjerlaugsen N, Holmen J, Hanssen KF, Birkeland KI, Berg JP (2009)
Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study - the HUNT study
Scand. J. Clin. Lab. Invest., 69 (2), PII 904888608-287
DOI 10.1080/00365510802538188

Yndestad A, Haukeland JW, Dahl TB, Bjoro K, Gladhaug IP, Berge C, Damas JK, Haaland T, Loberg EM, Linnestad P, Birkeland K, Konopski Z, Halvorsen B, Berge RK, Aukrust P (2009)
A Complex Role of Activin A in Non-Alcoholic Fatty Liver Disease
Am. J. Gastroenterol., 104 (9), 2196-2205
DOI 10.1038/ajg.2009.318

Aas AM, Hanssen KF, Berg JP, Thorsby PM, Birkeland KI (2009)
Insulin-Stimulated Increase in Serum Leptin Levels Precedes and Correlates with Weight Gain during Insulin Therapy in Type 2 Diabetes
J. Clin. Endocrinol. Metab., 94 (8), 2900-2906
DOI 10.1210/jc.2008-1005

Aas AM, Ohrvik J, Malmberg K, Ryden L, Birkeland KI, DIGAMI 2 Invest (2009)
Insulin-induced weight gain and cardiovascular events in patients with type 2 diabetes. A report from the DIGAMI 2 study
Diabetes Obes. Metab., 11 (4), 323-329
DOI 10.1111/j.1463-1326.2008.00964.x

Publications 2008

Birkenaes AB, Birkeland KI, Engh JA, Faerden A, Jonsdottir H, Ringen PA, Friis S, Opjordsmoen S, Andreassen OA (2008)
Dyslipidemia independent of body mass in anti psychotic-treated patients under real-life conditions
J. Clin. Psychopharmacol., 28 (2), 132-137
DOI 10.1097/JCP.0b013e318166c4f7

Johansen OE, Bjuro T, Endresen K, Blaasaas KG, Birkeland K, Aakhus S, Gullestad L (2008)
Heart rate adjustments and analysis of recovery patterns of ST-segment depression in type 2 diabetes
Int. J. Cardiol., 127 (1), 129-132
DOI 10.1016/j.ijcard.2007.04.022

Ribu L, Birkeland K, Hanestad BR, Moum T, Rustoen T (2008)
A longitudinal study of patients with diabetes and foot ulcers and their health-related quality of life: wound healing and quality-of-life changes
J. Diabetes Complications, 22 (6), 400-407
DOI 10.1016/j.jdiacomp.2007.06.006

Aasheim ET, Hofso D, Hjelmesaeth J, Birkeland KI, Bohmer T (2008)
Vitamin status in morbidly obese patients: a cross-sectional study
Am. J. Clin. Nutr., 87 (2), 362-369
DOI 10.1093/ajcn/87.2.362

Publications 2007

Birkenaes AB, Opjordsmoen S, Brunborg C, Engh JA, Jonsdottir H, Ringen PA, Simonsen C, Vaskinn A, Birkeland KI, Friis S, Sundet K, Andreassen OA (2007)
The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: A comparative study
J. Clin. Psychiatry, 68 (6), 917-923
DOI 10.4088/JCP.v68n0614

Johansen OE, Birkeland KI, Orvik E, Flesland O, Wergeland R, Ueland T, Smith C, Endresen K, Aukrust P, Gullestad L (2007)
Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects
Scand. J. Clin. Lab. Invest., 67 (3), 306-316
DOI 10.1080/00365510601045088

Johansen OE, Gullestad L, Blaasaas KG, Orvik E, Birkeland KI (2007)
Effects of structured hospital-based care compared with standard care for Type 2 diabetes - The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial
Diabetic Med., 24 (9), 1019-1027
DOI 10.1111/j.1464-5491.2007.02198.x

Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T (2007)
A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population
Qual. Life Res., 16 (2), 179-189
DOI 10.1007/s11136-006-0031-y

Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T (2007)
Health-related quality of life among patients with diabetes and foot ulcers: association with demographic and clinical characteristics
J. Diabetes Complications, 21 (4), 227-236
DOI 10.1016/j.jdiacomp.2007.02.001

Publications 2006

Bergersen BM, Schumacher A, Sandvik L, Bruun JN, Birkeland K (2006)
Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls
Scand. J. Infect. Dis., 38 (8), 682-689
DOI 10.1080/00365540500361302

Haukeland JW, Damas JK, Konopski Z, Loberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjoro K, Aukrust P (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
J. Hepatol., 44 (6), 1167-1174
DOI 10.1016/j.jhep.2006.02.011

Jenum AK, Anderssen SA, Birkeland KI, Holme I, Graff-Iversen S, Lorentzen C, Ommundsen Y, Raastad T, Odegaard AK, Bahr R (2006)
Promoting physical activity in a low-income multiethnic district: Effects of a community intervention study to reduce risk factors for type 2 diabetes and cardiovascular disease - A community intervention reducing inactivity
Diabetes Care, 29 (7), 1605-1612
DOI 10.2337/dc05-1587

Johansen OE, Birkeland KI, Brustad E, Aaser E, Lindahl AK, Midha R, Ueland T, Aukrust P, Gullestad L (2006)
Undiagnosed dysglycaemia and inflammation in cardiovascular disease
Eur. J. Clin. Invest., 36 (8), 544-551
DOI 10.1111/j.1365-2362.2006.01679.x

Publications 2004

Birkeland KI (2004)
Moderne prinsipper for insulinbehandling
In Diabeteshåndboken, Gyldendal akademisk, Oslo, s. 136-142
BIBSYS 041962524

Nissen-Lie G, Birkeland KI, Hemmersbach P, Skibeli V (2004)
Serum sTfR levels may indicate charge profiling of urinary R-hEPO in doping control
In Medicine and science in sports and exercise, American College of Sports Medicine, Madison, 36(2004)4, S. 588-93
BIBSYS 051823705

Stene LCM, Midthjell K, Jenum AK, Skeie S, Birkeland KI, Lund E, Joner G, Tell GS, Schirmer H (2004)
Hvor mange har Diabetes Mellitus i Norge?
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 124(2004)nr. 11, S. 1511-1514
BIBSYS 05184432x

Aas AM, Birkeland KI, Seljeflot I (2004)
Effects of lifestyle intervention and insulin treatment on PAI-1, Hs-CRP and TNF-alfa levels in patients with Type 2 diabetes
In Diabetologia, Springer, Berlin, 47(2004)S1, S. A295 Abstrakt nr 818
BIBSYS 052055523

Publications 2003

Birkeland KI, Gaarder PI, Petros B, Gundersen SG, Abebe F (2003)
The relationships between dehydroepiandrosterone sulphate(DHEAS), the intensity of Schistosoma mansoni infection and parasite-specific antibody responses: a cross sectional study in residents of endemic communities in north-easth Ethiopia
In APMIS, Blackwell Munksgaard, Copenhagen, 111(2003)2, s.319-28
BIBSYS 041704452

Birkeland KI, Kilhovd BK, Thorsby P, Torjesen PA, Ganss R, Vaaler S, Hanssen KF (2003)
Heterogeneity of non-insulin-dependent diabetes expressedas variability in insulin sensitivity, beta-cell function and cardiovascular risk profile
In Diabetic medicine, John Wiley, Chichester, 20(2003)1, s.37-45
BIBSYS 04170732x

Bleskestad IH, Birkeland KI (2003)
Forskjeller mellom perorale antidiabetika
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 123(2003)nr. 6, S. 808-809
BIBSYS 041707575

DeGroot PC, Hjeltnes N, Heijboer AC, Stal W, Birkeland KI (2003)
Effect of training intensity on physical capacity, lipid profile and insulin sensitivity in early rehabilitation of spinal cord injured individuals
In Spinal cord, Stockton, Houndmills, 41(2003)12, s.673-9
BIBSYS 04170777x

Jenum AK, Birkeland KI (2003)
"Mosjon på Romsås" (MORO): et helsefremmende intervensjonsprosjekt for å fremme fysisk aktivitet i et mulit-etnisk lokalsamfunn i Oslo øst
In Data fra SHUS: bakgrunn og anvendelse : tema, Institutt for kjemi, Norges teknisk-naturvitenskapelige universitet, Trondheim, s.55-63
BIBSYS 041718496

Jenum AK, Lorentzen C, Anderssen S, Birkeland KI, Holme I, Lund-Larsen PG, Ommundsen Y, Raastad T, Thelle D, Bahr R (2003)
Promoting physical activity in a multi-ethnic district: methods and baseline results of a pseudo-experimental intervention study
In European journal of cardiovascular nursing, Elsevier, Amsterdam, 10(2003)5, s.387-96
BIBSYS 041718623

Johansen OE, Birkeland KI (2003)
Preventing macrovascular disease in patients with type 2 diabetes mellitus
In American journal of cardiovascular pathology, Field & Woods, Philadelphia, 3(2003)4, s.283-97
BIBSYS 041719182

Kilhovd BK, Giardino I, Torjesen PA, Birkeland KI, Berg TJ, Thornalley PJ, Brownlee M, Hanssen KF (2003)
Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes
In Metabolism, Grune & Stratton, New York, 52(2003)2, s.163-7
BIBSYS 041719271

Kumar BN, Jenum AK, Birkeland KI, Holmboe-Ottesen G (2003)
Ethnic differences in the prevalence and determinants of diabetes type 2 in Oslo, Norway
In Diabetologia, Springer, Berlin, 46(2003)suppl 2, s.A37 abstract 101
BIBSYS 041734505

Os I, Høieggen A, Larsen A, Sandset PM, Djurovic S, Berg K, Os A, Birkeland KI, Westheim A (2003)
Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
In Journal of internal medicine, Blackwell Scientific Publ., Oxford, 253(2003)2, s.232-9
BIBSYS 041722221

Sandvik L, Dunlop O, Birkeland KI, Bruun JN, Bergersen BM (2003)
Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: results from a Norwegian study of 721 patients
In European journal of clinical microbiology & infectious diseases, Vieweg, Wiesbaden, 22(2003)12, s.731-6
BIBSYS 041705173

Thorsby PM, Blekastad I, Sletmo R, Hanssen KF, Birkeland KI (2003)
Non-glucose stimulated early insulin secretion is presenteven after long duration of type 2 diabetes
In Diabetologia, Springer, Berlin, 46(2003)suppl 2, s.A168 abstract 478
BIBSYS 041735986

Publications 2002

Birkeland KI (2002)
Kan vi forebygge diabetes?
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 122(2002)nr. 2, S. 155
BIBSYS 031265405

Publications 2001

Birkeland KI (2001)
Glitazoner: et nytt behandlingsprinsipp ved diabetes
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 121(2001)nr. 22, S. 2617-2619
BIBSYS 022031774

Birkeland KI (2001)
Glitazoner: et nytt behandlingsprinsipp ved diabetes
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 121(2001)nr. 22, S. 2617-2619
BIBSYS 022080759

Birkeland KI (2001)
Kan vi forebygge diabetes?
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 122(2001)nr. 2, S. 155
BIBSYS 022080899

Birkeland KI, Berg JP (2001)
Type 2 diabetes: preventable, but how?
In European journal of endocrinology, BioScientifa Ltd., Bristol, 145(2001)nr 5, s.573-575
BIBSYS 022029834

Haug E, Birkeland KI (2001)
Hormones and athletic performance
In Endocrinology and metabolism, McGraw-Hill, London, 2001, s.777-783
BIBSYS 022033173

Jenssen TG, Kumar PD, Lund KK, Brekke IB, Birkeland KI, Hartmann A (2001)
Preserved long-time beta cell function and glucose turnover in kidneypancreas transplant patients
In Diabetologia, Springer, Berlin, 44(2001)suppl 1, s.A73 Abstrakt nr 274
BIBSYS 022033688

Thorsby P, Kilhovd B, Birkeland KI (2001)
A single measurement of HBA1c or fasting blood glucose inthe early phase of type 2 diabetes predict long term glycaemic control
In Diabetologia, Springer, Berlin, 44(2001)suppl 1, s.A229 Abstrakt nr 880
BIBSYS 022035729

Aas AM, Bergstad I, Johannessen Ø, Birkeland KI (2001)
Intensified lifestyle intervention of insulin treatment in type 2 diabetic patients with failure on oral hypoglycemic agents: which is best?
In Diabetologia, Springer, Berlin, 44(2001)suppl 1, s.A231 Abstrakt nr 887
BIBSYS 022035907

Publications 2000

Birkeland KI (2000)
Insulinresistens: hva er det og hvordan måles det?
In Diabetes for helsepersonell, Norges diabetesforbund, Oslo, 15(2000)nr 4, s.4-6
BIBSYS 010869042

Birkeland KI, Claudi T, Hansteen V, Hanssen KF, Jenssen T, Jervell JA, Os I (2000)
Forebygging av hjerte- og karsykdom ved type 2-diabetes
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 120(2000)nr. 21, S. 2554-2559
BIBSYS 010758151

Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallén J, Haug E, Bahr R (2000)
Effect of rhEPO administration on serum levels of sTfR and cycling performance
In Medicine and science in sports and exercise, American College of Sports Medicine, Madison, 32(2000)nr 7, s.1238-1243
BIBSYS 010829059

Haug E, Birkeland KI, Hemmersbach H (2000)
Doping og idrettsutøvere
In Medicinsk årbog 2000, s.9-18
BIBSYS 010834362

Kilhovd B, Giardino I, Torjesen PA, Birkeland KI, Thornalley PJ, Brownlee M, Hanssen KF (2000)
Increased serum methylglyoxal-derived hydroimidazolone inpatients with type 2 diabetes
In Diabetologia, Springer, Berlin, 43(2000)Suppl.1, s.A53 210
BIBSYS 01078408x

Kilhovd B, Giardino I, Torjesen PA, Birkeland KI, Thornalley PJ, Brownlee M, Hanssen KF (2000)
Increased serum methylglyoxal-derived hydroimidazolone inpatients with type 2 diabetes
In European journal of endocrinology, Supplementum, BioScientifica Ltd., Bristol, 142(2000)Suppl 1, s.26
BIBSYS 010890785

Os I, Hofstad AE, Brekke M, Abdelnoor M, Nesheim BI, Jacobsen AF, Birkeland KI, Larsen A, Midtbø K, Bestheim A (2000)
The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins
In Journal of internal medicine, Blackwell Scientific Publ., Oxford, 247(2000)nr 4, s.433-443
BIBSYS 010830138

Thorsby P, Kilhovd B, Sletmo R, Martinsen S, Birkeland KI (2000)
Blodsukkersenkende behandling ved type 2-diabetes
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 120(2000)nr. 20, S. 2434-2440
BIBSYS 010831576

Tonstad S, Birkeland KI (2000)
Fedmeepidemien: har slankepiller en plass i behandlingen?
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 120(2000)nr. 17, S. 1997-2001
BIBSYS 010831657

Publications 1999

Birkeland KI (1999)
The future of doping control in athletes: issues related to blood sampling
In Sports medicine, Adis International, Auckland, 28(1999)nr 1, S. 25-33
BIBSYS 991506774

Publications 1995

Birkeland KI (1995)
Type 2 diabetes mellitus: studies on insulin secretion and action in relation to metabolic control and cardiovascular risk factors
Hormone Laboratory, Aker University Hospital, Oslo University, Oslo, 1 b. (flere pag.)
BIBSYS 950450715, ISBN 82-993390-0-6

Publications 1994

Birkeland KI (1994)
Towards blood sampling in doping control: the road ahead
In Blood samples in doping control: proceedings of the Second International Symposium on Drugs in Sport : Towards the Use of Blood Samples in Doping Control? Lillehammer, Norway, August 29-31, 1993, Pensumtjeneste, Oslo, S. 203-205
BIBSYS 990137910